{
    "nctId": "NCT01693731",
    "briefTitle": "Oral Health in Breast Cancer Survivors on Aromatase Inhibitors",
    "officialTitle": "Oral Health in Breast Cancer Survivors on Aromatase Inhibitors",
    "overallStatus": "COMPLETED",
    "conditions": "Periodontal Disease, Quality of Life",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 300,
    "primaryOutcomeMeasure": "Periodontal diseases",
    "eligibilityCriteria": "Inclusion Criteria:\n\nPostmenopausal as defined by NCCN (any of the following)\n\n* Prior bilateral oophorectomy\n* Age equal to or greater then 60 years of age\n* Age less then 60 and amenorrheic for 12 or more months in the absence of chemotherapy, tamoxifen, toremifen or ovarian suppression and FSH and estradiol in the postmenopausal range\n* If taking tamoxifen or toremifen and age less then 60y, then FSH and plasma estradiol level in postmenopausal ranges\n\nInformed consent- Individuals capable of consenting and self administering the survey instrument Dentate- At least 15 teeth present.\n\nAI users:\n\n* Diagnosis of BCa- Histologic confirmed diagnosis of BCa: Stage 0, I, II, or III with no evidence of metastatic disease.\n* Treatment- AI as clinically indicated (AI may be anastrozole, exemestane or letrozole) \\> 1 month. Subjects may have had prior tamoxifen or raloxifene. Subjects may have had chemotherapy and/or radiation therapy. Must be within the first year of consecutive AI therapy. If a subject started AI, discontinued, then restarted, they will be accepted into the study.\n\nControls:\n\n* No Diagnosis of cancer.- Patients must not have a diagnosis of any cancer (Not including a history of localized thyroid or skin cancer).\n\nExclusion Criteria:\n\nMedical history\n\n* Metastatic BCa (AI treated group: fully resected locally recurrent disease is permitted if the patient has been rendered without evidence of disease).\n* Significant psychiatric illness/social situations that would preclude completion of questionnaire.\n\nMedications\n\n* Chronic medications known to affect the periodontal status (calcium antagonist, anti-convulsives, immunosuppressives (\\> prednisone 7.5mg daily). NSAIDS and bisphosphonates are permitted.\n* Premedication- Conditions that require antibiotic therapy will be evaluated on a case-by-case basis. (Patients taking prophylaxis for joint replacements will not be excluded.)",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}